R. Boggon

First name
R.
Last name
Boggon
Boggon, R., van Staa, T. P., Timmis, A., Hemingway, H., Ray, K. K., Begg, A., et al. (2011). Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction\textendasha hospital registry-primary care linked cohort (MINAP-GPRD). Eur Heart J. http://doi.org/10.1093/eurheartj/ehr340
Boggon, R., . Y. Lip, G., Gallagher, A. M., & van Staa, T. P. (2012). Resource utilization and outcomes in patients with atrial fibrillation: a case control study. Appl Health Econ Health Policy. http://doi.org/10.2165/11599940-000000000-00000
Boggon, R., Eaton, S., Timmis, A., Hemingway, H., Gabriel, H., Minhas, I., & van Staa, T. P. (2012). Current prescribing of statins and persistence to statins following ACS in the UK: a MINAP/GPRD study. Br J Cardiol.
Boggon, R., Hubbard, R., Smeeth, L., Gulliford, M., Cassell, J., Eaton, S., et al. (2013). Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study. BMC Pulm Med. http://doi.org/10.1186/1471-2466-13-32
Boggon, R., van Staa, T. P., Chapman, M., Gallagher, A. M., Hammad, T. A., & Richards, M. A. (2013). Cancer recording and mortality in the General Practice Research Database and linked cancer registries. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3374
Herrett, E., Shah, A. D., Boggon, R., Denaxas, S., Smeeth, L., Van Staa, T., et al. (2013). Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study. Bmj. http://doi.org/10.1136/bmj.f2350
Boggon, R., Timmis, A., Hemingway, H., Raju, S., Malvestiti, F. M., & van Staa, T. P. (2014). Smoking cessation interventions following acute coronary syndrome: a missed opportunity?. Eur J Prev Cardiol. http://doi.org/10.1177/2047487312460517
Baril, L., Rosillon, D., Willame, C., Angelo, M. G., Zima, J., van den Bosch, J. H., et al. (2015). Risk of spontaneous abortion and other pregnancy outcomes in 15-25 year old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Vaccine. http://doi.org/10.1016/j.vaccine.2015.07.024
Willame, C., Rosillon, D., Zima, J., Angelo, M. G., Stuurman, A. L., Vroling, H., et al. (2016). Risk of new onset autoimmune disease in 9- to 25-year-old women exposed to human papillomavirus-16/18 AS04-adjuvanted vaccine in the United Kingdom. Hum Vaccin Immunother. http://doi.org/10.1080/21645515.2016.1199308